This company has been marked as potentially delisted and may not be actively trading. Lianluo Smart (LLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock LLIT vs. INFU, NSPR, CTCX, TMDIF, HSAQ, GBS, PETV, RVP, BTCY, and INVOShould you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include InfuSystem (INFU), InspireMD (NSPR), Carmell (CTCX), Titan Medical (TMDIF), Health Sciences Acquisitions Co. 2 (HSAQ), GBS (GBS), PetVivo (PETV), Retractable Technologies (RVP), Biotricity (BTCY), and INVO Bioscience (INVO). These companies are all part of the "medical" sector. Lianluo Smart vs. Its Competitors InfuSystem InspireMD Carmell Titan Medical Health Sciences Acquisitions Co. 2 GBS PetVivo Retractable Technologies Biotricity INVO Bioscience Lianluo Smart (NASDAQ:LLIT) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations. Which has higher earnings & valuation, LLIT or INFU? InfuSystem has higher revenue and earnings than Lianluo Smart. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianluo Smart$380K261.65-$4.45MN/AN/AInfuSystem$137.58M0.86$870K$0.1440.43 Do institutionals & insiders hold more shares of LLIT or INFU? 28.8% of Lianluo Smart shares are held by institutional investors. Comparatively, 71.1% of InfuSystem shares are held by institutional investors. 22.9% of Lianluo Smart shares are held by insiders. Comparatively, 11.4% of InfuSystem shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is LLIT or INFU more profitable? InfuSystem has a net margin of 1.12% compared to Lianluo Smart's net margin of 0.00%. InfuSystem's return on equity of 2.78% beat Lianluo Smart's return on equity.Company Net Margins Return on Equity Return on Assets Lianluo SmartN/A N/A N/A InfuSystem 1.12%2.78%1.41% Do analysts rate LLIT or INFU? InfuSystem has a consensus price target of $12.50, suggesting a potential upside of 120.85%. Given InfuSystem's stronger consensus rating and higher possible upside, analysts plainly believe InfuSystem is more favorable than Lianluo Smart.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lianluo Smart 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 3 Strong Buy rating(s) 4.00 Which has more risk & volatility, LLIT or INFU? Lianluo Smart has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500. Comparatively, InfuSystem has a beta of 1.81, indicating that its share price is 81% more volatile than the S&P 500. Does the media prefer LLIT or INFU? In the previous week, InfuSystem had 5 more articles in the media than Lianluo Smart. MarketBeat recorded 5 mentions for InfuSystem and 0 mentions for Lianluo Smart. InfuSystem's average media sentiment score of 0.70 beat Lianluo Smart's score of 0.00 indicating that InfuSystem is being referred to more favorably in the news media. Company Overall Sentiment Lianluo Smart Neutral InfuSystem Positive SummaryInfuSystem beats Lianluo Smart on 12 of the 14 factors compared between the two stocks. Get Lianluo Smart News Delivered to You Automatically Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LLIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LLIT vs. The Competition Export to ExcelMetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$99.43M$71.06M$5.59B$9.59BDividend YieldN/AN/A4.71%4.03%P/E RatioN/A6.2030.1620.55Price / Sales261.65149.93445.9397.93Price / CashN/A18.4136.0158.40Price / Book-76.228.188.405.78Net Income-$4.45M-$25.92M$3.25B$259.21M Lianluo Smart Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LLITLianluo SmartN/A$44.97-20.0%N/A+6,365.3%$99.43M$380K0.006Gap DownINFUInfuSystem3.3999 of 5 stars$5.75+4.4%$12.50+117.4%N/A$115.80M$137.58M95.85410NSPRInspireMD2.4985 of 5 stars$2.51-0.4%$4.50+79.3%-14.1%$76.89M$7.03M-3.3550News CoverageGap UpCTCXCarmellN/A$3.63-16.0%N/A+252.3%$75.89M$32.84K0.0014Gap DownTMDIFTitan MedicalN/A$0.38+2.8%N/A+914.8%$43.37M$17.63M-0.3050HSAQHealth Sciences Acquisitions Co. 2N/A$3.16+2.3%N/A-54.9%$35.43MN/A0.004GBSGBSN/A$2.15+0.5%N/A+14.2%$32.01MN/A-3.847Gap UpPETVPetVivoN/A$0.84+0.6%N/A+23.5%$20.41M$1.05M-1.8620News CoverageRVPRetractable Technologies1.27 of 5 stars$0.67+0.8%N/A-34.5%$20.06M$33.75M-1.24240BTCYBiotricityN/A$0.51+6.3%N/A-38.1%$12.71M$12.06M-0.4740Gap DownINVOINVO BioscienceN/A$2.55+0.9%N/AN/A$9.71M$5.77M0.0025Gap Up Related Companies and Tools Related Companies InfuSystem Competitors InspireMD Competitors Carmell Competitors Titan Medical Competitors Health Sciences Acquisitions Co. 2 Competitors GBS Competitors PetVivo Competitors Retractable Technologies Competitors Biotricity Competitors INVO Bioscience Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LLIT) was last updated on 7/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lianluo Smart Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lianluo Smart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
